Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.63
Delayed Data
As of 3:57pm ET
 -0.025 / -0.94%
Today’s Change
2.25
Today|||52-Week Range
4.08
+0.96%
Year-to-Date
No recent news for AcelRx Pharmaceuticals Inc.

Today’s Trading

Previous close2.65
Today’s open2.65
Day’s range2.55 - 2.75
Volume133,251
Average volume (3 months)215,197
Market cap$118.0M
Dividend yield--
Data as of 3:57pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-58.33%
Earnings growth (this year)-17.54%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-9.89%
P/E ratioNM
Price/Sales6.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV+0.05+2.13%
ARLZAralez Pharmaceutica...-0.02-1.41%
VTLVital Therapies Inc-0.05-1.56%
ORMPOramed Pharmaceutica...-0.16-1.86%
Data as of 3:57pm ET, 05/24/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$17.4M
Annual profit (last year)-$43.2M
Net profit margin-248.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Vincent J. Angotti
CFO &
Head-Business Development
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts